ATEC Form 144 shows 15,625 shares proposed sale; prior 152,688 shares sold
Rhea-AI Filing Summary
Alphatec Holdings, Inc. filed a Form 144 reporting a proposed sale of 15,625 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $245,625. The sale is listed for execution approximately on 08/13/2025 on NASDAQ, against a total of 147,983,775 shares outstanding.
The securities were acquired on 02/24/2023 as 7,011 Performance Stock Units and 8,614 Restricted Stock Units, which together equal the 15,625 shares proposed for sale. The filing also discloses prior sales in the past three months totaling 152,688 shares for gross proceeds of approximately $1,971,447.50, several of which are identified as 10b5-1 plan transactions. The filer attests to no undisclosed material adverse information in connection with the notice.
Positive
- None.
Negative
- None.
Insights
TL;DR: Proposed sale is small relative to outstanding shares; recent 3‑month insider sales total ~152.7k shares ($1.97M), a modest amount.
The proposed 15,625‑share sale represents approximately 0.0106% of the company's outstanding shares (15,625 of 147,983,775), indicating negligible direct dilution or market impact from this single transaction. Recent cumulative insider sales of 152,688 shares equal roughly 0.103% of outstanding shares and generated about $1.97M in gross proceeds. These numbers are small relative to the total share base, so from a pure ownership and dilution perspective the activity is immaterial.
TL;DR: Sales include multiple 10b5-1 plan executions and the filer certifies no undisclosed material information, indicating procedural compliance.
The filing documents that several prior sales were executed under Rule 10b5-1 arrangements for the named individual, which typically reflect preplanned dispositions rather than opportunistic trading. The filer also includes the standard representation that no material nonpublic information is known. These elements suggest the transactions follow established insider‑trading compliance processes; they do not, by themselves, signal material corporate governance or disclosure concerns based on the information provided.